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Abstract 
For severe muscle damage, tissue engineering has become a viable option to culture 
muscle tissues with the ultimate goal of implantation.  However, the tissues are typically cultured 
on permanent scaffolds which would elicit a foreign body response if placed in the body. To 
avoid this, biological scaffolds are ideal for tissue culture and limiting any negative reactions.   A 
sacrificial scaffold can be used to gather extracellular matrix (ECM), which can then be used as 
the primary scaffold for culturing tissues for implantation.  To reach the ultimate goal of 
implanting muscle tissue, an understanding of how to produce ECM on a larger scale must also 
be gained.  Supplementing culture media with pro-fibrotic molecules is an option to consider for 
enhancing ECM formation.  
 Two conditions, molecular crowding and the addition of transforming growth factor beta 
1 (TGF-β1), were considered.  In addition, the effect of the concentration of TGF-β1 on material 
yield was also analyzed. In the first experiment, molecular crowding macromolecules, TGF-β1, 
and a control with no additives were considered. .  For the second experiment, concentrations of 
TGF-β1 at 0.5, 1, and 5 ng/mL were added to culture media and material yield was compared to 
a control set with no TGF-β1. Cells were cultured for three weeks on sacrificial scaffolds under 
varied culture conditions, the scaffolds were removed, and the mass of ECM collected was 
measured.  The material yields were then analyzed using an analysis of variance (ANOVA) and 
linear regression.   
The results from the first experiment indicated that neither molecular crowding nor TGF-
β1 increase the material yield.  In the second experiment, it appeared that the addition of TGF-β1 
at all concentrations increased material yield.  This could indicate even less TGF-β1 could be 
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added to culture media to increase material yield.  Additionally, the amount of fetal bovine 
serum (FBS) added to the culture media was different between the two experiments, which could 
explain the conflicting results regarding the effect of TGF-β1 on material yield in the two 
experiments.  Based on the results of the data, ECM formation can be enhanced by 
supplementing the culture media with TGF-β1 at a concentration as low as 0.5 ng/mL. 
1. Introduction 
For minor muscle damage, the recommended treatment is time, rest, and physical 
therapy.  The body has its own mechanisms of healing muscle damage at the cellular level.  
However, if the muscle damage is severe enough, the body will not be able to repair the damage 
on its own.  Tissue engineering has become a viable option to create muscle tissues in lab 
settings with the ultimate goal of implanting the tissues in patients that have suffered severe 
muscle damage.  Typically, tissues are cultured on permanent scaffolds.  If permanent scaffolds 
were implanted, a foreign body response could be triggered. A biological scaffold is ideal for 
limiting foreign body responses.  A sacrificial scaffold can be utilized to collect the extracellular 
matrix (ECM) secreted by cells, which can then be used as the primary scaffold for culturing 
tissues for implantation. The ECM is the primary structural biological material in all tissues and 
organs [1].  Therefore, using it as a scaffold would better replicate true biological conditions 
while decreasing the risk for a foreign body response.     
In lab settings, engineering muscle tissues on a small scale is a common occurrence.  
However, to reach the ultimate goal of implanting muscle tissue, an understanding of how to 
produce ECM on a larger scale must be gained.  Supplementing the culture media with pro-
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fibrotic molecules is an option to consider for enhancing the production of ECM.  However, 
under standard media conditions, ECM formation in vitro is a slow process.   
In this study, two fibrogenic culture additives, molecular crowding and the addition of 
transforming growth factor beta 1 (TGF-β1), were considered.   
Molecular crowding is the concept of using macromolecules in the culture media to 
crowd the cells [2].  In the process of culturing tissues, cells are harvested and seeded onto 
scaffolds while being “bathed in a large volume of non-crowded aqueous medium” [1].   To 
better represent an in vivo environment, macromolecules are added to the culture media to 
provide more crowded surroundings.   Ficoll (Fc) and Dextran Sulfate (DxS) are macromolecules 
used to simulate molecular crowding conditions (Fig. 1).  Both molecules have large molecular 
weights, but the main difference between the two is Fc is neutral and DxS has a negative charge.  
Crowding the media with macromolecules like Fc and DxS has been shown to increase the 
chemical activity of the cells, which would promote collagen and ECM formation.       
  
 
TGF-β1 is a protein that is commonly used to induce cells to synthesize and contract 
ECM.  It is a cytokine that has been believed to be a central mediator of the fibrotic response and 
enhancement of collagen expression [5].  Adding TGF-β1 to the culture media will increase 
ECM formation in the tissues, which will increase the amount of tissue formed.  
a 
b 
Fig. 1 – (a) Chemical structure of Ficoll [3] (b) Chemical Structure of Dextran Sulfate. [4] 
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To determine whether molecular crowding or the addition of TGF-β1 will significantly 
increase the amount of ECM formed, tissues were cultured in these conditions and the average 
material yields were examined.  Also, there has been speculation about whether or not material 
yield is sensitive to TGF-β1 concentration.  To answer this question, another study was 
conducted to determine the effect of TGF-β1 concentration on the material yield.  
2. Materials and Methods  
2.1. Scaffold Preparation 
To produce the sacrificial scaffolds, a 
mold was made by using a small metal plate 
covered with a 0.3 millimeter thick soft 
rubber.  A 1 centimeter diameter hole was cut 
through the rubber and the circle was removed 
leaving the metal plate visible.  This step was 
completed until there was not any more space 
for holes.  The mold is shown in Figure 2.  
The holes were then filled with a moist sugar 
mixture that provided the backbone of the 
scaffold, as shown in Figure 2.  Using a 
spatula, sugar was mixed with water at a ratio 
of 10 g of sugar to 200 µL of water until the 
water is evenly distributed.  When filling the 
holes, it is important to not pack the sugar in 
Fig. 2 – (a) The mold for scaffolds  
(b) Addition of sugar mixture to mold 
a 
b 
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too tight.  Once all of the holes were filled with the moist sugar mixture, the entire mold was 
placed in a drying oven overnight.  
A 10% polyurethane solution is used to make the foam scaffolds.  The solution was 
prepared by dissolving 2 g of polyurethane pellets (Tecoflex, SG-80A, Lubrizol, Cleveland, OH) 
in 20 mL of dimethylacetamide (DMAC) 
(Sigma, St. Louis, MO) in a 100 mL round 
bottom flask.  A stirring pellet was then added 
and the mixture was placed on a hot plate.  
The solution was heated to 60°C and left 
overnight.  Once the moist sugar mixture was 
dry and the polyurethane pellets were 
dissolved in DMAC, the 10% polyurethane 
solution was drizzled over each sugar-filled 
hole as shown in Figure 3.  Particular 
attention was given such that there was not 
any solution pooled at the surface of the sugar 
mold.   
The final step in preparing the 
scaffolds relied on solubility principles. Since 
sugar was water-soluble and polyurethane was 
not, the entire mold was placed in a small 
container of water and left over night.  When 
Fig. 3 – (a) Addition of polyurethane solution to 
sugar (b) Placement of mold with sugar and 
polyurethane solution into water container  
(c) Structure of polyurethane scaffold 
a 
b 
c 
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completed, only polyurethane foam scaffolds remained in each hole.  The foams were removed 
from the mold, placed in a clean beaker filled with DI water, and stirred to ensure all of the 
DMAC and sugar was rinsed from the scaffolds.   
2.2.1. Media Preparation – Molecular Crowding 
For the molecular crowding experiment, four different conditions were analyzed: Fc and 
DxS as the molecules used for molecular crowding, TGF-β1, and a control group with no 
molecular crowding or TGF-β1.  Each condition had different additives in the media.  Since 
molecular crowding is the focus of the experiment, it was decided to use the media mixture that 
is suggested for Fc and DxS [2].  The media mixture (0.5% FBS media) contained Dulbecco's 
Modified Eagle Medium: Nutrient Mixture F-12 (DMEM F12) (Gibco, Grand Island, NY), 
Glutamax (10 µL/mL) (Gibco, Grand Island, NY), Gentamicin (1 µL/mL) (Gibco, Grand Island, 
NY), and Fetal Bovine Serum (FBS) (5 µL/mL) (Gibco, Grand Island, NY), where Glutamax is 
used to improve growth effiiciency, Gentamicin is an antibiotic, and FBS is a growth 
supplement.  The mixture was prepared in sterile conditions and stored at 4°C for use as needed.  
Media was also supplemented with 1mM ascorbic acid.  To prepare a 10 mM ascorbic 
acid stock solution, 75 mg of L-Ascorbic Acid-2-Phosphate (Sigma, St. Louis, MO) and 25 mg 
of L-Ascorbic Acid (Sigma, St. Louis, MO) is mixed in 50 mL of media.  Once everything was 
dissolved, the ascorbic acid was sterile filtered using a sterile filter syringe.  Ascorbic acid is 
very unstable and rapidly oxidizes in aqueous solutions.  To maintain the ascorbic acid 
properties, the ascorbic acid was separated into 6 mL aliquots and kept at -80°C.  The aliquots 
were thawed and used as needed.   
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To avoid weighing Fc and DxS for each media change, Fc and DxS solutions were 
prepared and stored for the duration of the experiment. For the Fc solution, Fc 70 (GE 
Healthcare, Pittsburgh, PA) at 37.5 mg/mL was mixed with Fc 400 (GE Healthcare, Pittsburgh, 
PA) at 25 mg/mL [2].  At this ratio, 18.75 g of Fc 70 and 12.50 g of Fc 400 were mixed with 500 
mL of the 0.5% FBS media and stored for use throughout the experiment.  The DxS solution was 
prepared at 100 µg/mL [2].  Since this is such a small mass, it was decided to prepare the DxS 
solution as a 10X concentrated solution.  To mix the 10X solution, 60 mg of DxS 500 kDa (pK 
Chemicals, New York, NY) were mixed with 60 mL of the 0.5% FBS media.  Each solution was 
sterilized by filtration to decrease the chance of contamination. In addition, TGF-β1 (Sigma, St. 
Louis, MO) was added at a concentration of 4 ng/mL.  The media composition for each well is 
described in Table 1.  
Table 1: Cell-Feeding Formula for each Condition (per well) 
Control TGF-β1 Fc DxS 
0.5% FBS media 
1 mM Ascorbic Acid 
0.5% FBS media 
1 mM Ascorbic Acid 
4 ng/mL TGF-β1 
0.5% FBS media 
37.5 mg/mL Fc 70 
25 mg/mL Fc 400 
1 mM Ascorbic Acid 
0.5% FBS media 
1 mM Ascorbic Acid 
100 µg/mL DxS  
 
2.2.2. Media Preparation – TGF-β1 
Four TGF-β1 conditions were examined during this experiment.  The four conditions 
were the control with no TGF-β1, 0.5 ng of TGF-β1 per mL of media, 1 ng of TGF-β1 per mL of 
media, and 5 ng of TGF-β1 per mL of media.  The media (10% FBS media) consisted of the 
standard mix of DMEM F12 with Glutamax (10 µL/mL), Gentamicin (1 µL/mL), and Fetal 
Bovine Serum (FBS) (10 µL/mL).   
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Since the amount of TGF-β1 used was such a small amount, it was deemed very difficult 
to add TGF-β1 to each individual well.  Because of this, the media was mixed with ascorbic acid 
and TGF-β1 for the entire six-well plate and then distributed to each individual well at the time 
of changing the media. In 30 mL plastic vials, 27 mL of 10% FBS media and 3 mL of ascorbic 
acid were placed.  Then, a micropipette was used to add the required amount of TGF-β1 for each 
condition. The TGF-β1 mixtures for each six well plate are listed in Table 2.  
Table 2: TGF-β1 Mixture for 6-Well Plate 
TGF-β1 – 0.5 ng/mL TGF-β1 – 1 ng/mL TGF-β1 – 5 ng/mL 
27 mL 10% FBS media 
3 mL Ascorbic Acid 
3 µL TGF-β1 
27 mL 10% FBS media 
3 mL Ascorbic Acid 
6 µL TGF-β1 
27 mL 10% FBS media 
3 mL Ascorbic Acid 
30 µL TGF-β1 
 
It was assumed that the media, ascorbic acid, and TGF-β1 had a constant concentration 
throughout the 30 mL of solution.  An auto pipette was used to distribute 5 mL of solution to 
each well for each TGF-β1 condition. The cell feeding formulas for each well is listed in Table 3.  
Table 3: Cell-Feeding Formula for each Condition (per well) 
Control TGF-β1 – 0.5 ng/mL TGF-β1 – 1 ng/mL TGF-β1 – 5 ng/mL 
10% FBS media 
1 mM Ascorbic Acid 
10% FBS media 
1 mM Ascorbic Acid  
0.5 ng/mL TGF-β1 
10% FBS media 
1 mM Ascorbic Acid  
1 ng/mLTGF-β1 
10% FBS media 
1 mM Ascorbic Acid  
5 ng/mL TGF-β1 
 
2.3. Tissue Culture 
For both experiments, rat skeletal muscle myoblasts (L6, ATCC, Manasas, VA)  were 
used.  They were expanded in flasks and the media was changed 3 times per week.  Once 
confluent, the cells were split into two flasks and continued until it was believed there were 
enough cells to seed 2 million cells per scaffold.  This procedure was continued until sufficient 
numbers of cells were produced such that scaffolds were incubated with 2 million cells per 
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scaffold. To confirm the approximate number of cells, the cells were removed from the flasks 
and counted using a hemocytometer.  
Before cells could be seeded on the scaffolds, the scaffolds had to be prepared.  Thus far, 
the scaffold preparation has not been sterile.  Therefore, the scaffolds were sterilized to prevent 
contamination.  To sterilize the scaffolds, the required number of scaffolds were placed in a Petri 
dish, covered with 70% alcohol, and placed in a vacuum desiccator for 20-30 minutes.  Then, the 
Petri dishes were removed from the container and the alcohol was aseptically aspirated from the 
Petri dishes.  The scaffolds were then rinsed with phosphate buffered saline (PBS) (Sigma, St. 
Louis, MO) three times for 2-3 minutes per rinse.  Finally, the scaffolds were covered with 
fibronectin (Sigma, St. Louis, MO) and left overnight in the 4°C cooler with parafilm sealing all 
edges of the Petri dishes.  
The sterilized scaffolds were placed in six-well plates, with one scaffold per well.  To 
seed the cells onto the scaffolds, the amount of cell solution that contains 1 million cells was 
determined based on the number of cells counted.  Using a micropipette, 1 million cells were 
seeded onto the scaffold by carefully dropping the cell solution onto the scaffold.  Once all of the 
scaffolds were seeded, the six-well plates were placed in the incubator for 30 minutes.  Then the 
scaffolds were flipped, another one million cells were seeded on the scaffolds, and the six-well 
plates were placed incubator for another thirty minutes.  Finally, the scaffolds were covered with 
10% FBS media and left in the incubator overnight.   
Media was changed three times per week for three weeks.  Each six-well plate contained 
the six samples for each condition.  The feeding outline followed the protocols previously 
mentioned in sections 2.2.1. and 2.2.2.    
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2.4. Scaffold Removal 
After three weeks of culturing the tissues for each experiment, the tissues were removed 
from the six-well plates and placed in plastic vials.  All six tissues from each condition were 
placed in the same vial, and the vials were then placed at -80°C.  To preserve the material, the 
tissues were freeze-dried.    
After the tissues were freeze-dried, the tissues were thawed and covered with a 4% 
paraformaldehyde (Sigma, St. Louis, MO) solution and left overnight at 4°C.  The 
paraformaldehyde solution fixed the tissues and cells by terminating any ongoing biochemical 
processes.  The next day, each tissue was removed from the plastic vials and placed individually 
in a scintillation vial.  
To remove the scaffolds from the tissues, 
DMAC was used to dissolve the polyurethane foam 
scaffolds by carefully rinsing the foams.  A 
micropipette was used to add and remove each rinse 
being careful not to tear the tissue.  Four rinses were 
performed to ensure the entire polyurethane scaffold 
was dissolved.  For the first rinse, 3-5 mL was used to 
cover the tissue in the scintillation vial.  After 20-30 
minutes, the first rinse was removed and a second rinse 
was left overnight at room temperature.  The third and 
fourth rinses were also left overnight.  Figure 4 
displays a tissue being rinsed with DMAC to remove 
Fig. 4 – Tissue during rinse of sacrificial 
scaffold  
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the sacrificial foam. 
After the fourth rinse, the polyurethane scaffold was removed and only the muscle tissue 
remained.  However, to rinse the DMAC from the muscle tissues, DI water was used.  The rinse 
process for the DI water was similar to the rinse process with DMAC.  After the fourth rinse, one 
mL of DI water was added to each scintillation vial and placed in -80°C.  The tissues were then 
freeze-dried.   
2.5.1. Data Analysis – Molecular Crowding 
To measure tissue formation, the material yield for each tissue was measured after the 
tissues had been freeze dried.  The mass of each tissue was weighed to the nearest tenth of a 
milligram, and the average material yield was determined for each condition.  To determine any 
significant differences between conditions of the molecular crowding experiment, an analysis of 
variance between groups (ANOVA) was used.  It is important to note that ANOVA will only 
report a difference between groups.  To determine which groups were significantly different, 
post-hoc testing was conducted.  The post-hoc testing used was the Tukey Test.    
2.5.2. Data Analysis – TGF-β1  
The average material yield for each concentration of TGF-β1 was measured by weighing 
the mass of each tissue.  An ANOVA test was used to determine if there was a difference in the 
material yield for each condition, and the Tukey test was used as post-hoc testing.  Additionally, 
linear regression analysis was used to determine the relationship between the concentration of 
TGF-β1 added to the culture media and the material yield. Using the output data of the linear 
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regression analysis, the R-squared value and the significance F value (p=0.05)  were used to 
determine significance.    
3. Results 
3.1. Molecular Crowding 
The average material yield for the control, TGF-β1, Fc, and DxS was 0.65±0.085 mg, 
0.88±0.060 mg, 0.8±0.097 mg, 0.17±0.071 mg, respectively (Fig. 5).  According to the ANOVA 
(p=0.05) analysis, there was a significant difference between conditions.  Post-hoc testing 
confirmed there was a significant difference in the average material yield between DxS and the 
control, TGF-β1, and Fc.  
 
 
 
 
 
 
 
 
 
 
3.2. TGF-β1 
The average material yield for the TGF-β1 concentrations of 0, 0.5, 1 and 5 ng/mL was 
0.51±0.074 mg, 1.83±0.076 mg, 1.33±0.067 mg, and 1.53±0.163 mg, respectively (Fig. 6). The 
Fig. 5 – (A) Display of the relative size and the structure of material formed in each 
condition (B) Average material yield comparing TGF-β and molecular crowding 
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a b 
Fig. 6 – (a) Average material yield for the different TGF-β1 conditions (b) Scatter plot of 
average material yield versus TGF-β1 concentrations with trend line  
ANOVA (p=0.05) confirmed there was a significant difference between the tested conditions.  
Post-hoc testing showed that adding TGF-β1 significantly increased the average material yield.  
In addition, it was also concluded that adding TGF-β1 at 0.5 ng/mL will significantly increase 
average material yield compared to adding TGF-β1 at 1 ng/mL.  However, there is not a 
significant difference between adding TGF-β1 at 0.5 ng/mL and 5 ng/mL. 
Linear regression analysis indicates the correlation between the concentration of TGF-β1 
and the material yield was low.  The R-squared value was 0.138, which specified that only 13% 
of the material yield was attributed to the concentration of TGF-β1 and did not signify a 
relationship between TGF-β1 concentration and the material yield. The significance F value was 
0.62, which was far greater than the notable value of 0.05.  Since the significance F value was 
greater than p = 0.05, it was determined that there was not a statistically significant association 
between the material yield and the TGF-β1 concentration.  This also indicated there was not a 
linear correlation between the TGF-β1 concentration and the material yield.  
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4. Discussion 
Even though there was an increase in the average material yield of the Fc and the TGF-β1 
conditions compared to the control, the difference was not significant (p=0.05) under these 
conditions.  It even appeared that DxS hindered material yield. This study displayed results that 
indicate molecular crowding will not increase the material yield of the ECM.   
The TGF-β1 experiment demonstrated that there was not a linear relationship between the 
amount of TGF-β1 added to the media and the material yield. The concentrations of 0.5 ng/µL 
and 5 ng/µL yielded the highest amounts of tissue. It is unknown why the material yield at 1 
ng/mL decreased.  Since there is not a significant difference between concentrations of 0.5 
ng/mL and 5 ng/mL of TGF-β1, 0.5 ng/µL is sufficient to add to the media to increase ECM 
yield.  However, since the material yield for all concentrations of TGF-β1 were all similar and 
increased compared to the control, this could indicate that an even lower concentration of TGF-
β1 could be used as a supplement to increase material yield.  Determining this value could prove 
beneficial because TGF-β1 is an expensive product and using as little as possible while still 
maximizing results would be more cost efficient. Although there was not a linear correlation 
between material yield and TGF-β1 concentrations of 0.5, 1, and 5 ng/mL, there may be a linear 
correlation for concentrations between 0 and 0.5 ng/mL.  
In the first experiment, adding TGF-β1 does not make a significant difference in the 
material yield.  However, for the second experiment, adding TGF-β1 at any concentration 
yielded a significant increase in the amount of tissue formed.  The only difference between the 
two conditions was the amount of FBS used in the media.  This could suggest the importance of 
using a 10% FBS media versus a 0.5% FBS media when aiming for a high material yield.   
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Based on this study, it can be concluded that ECM formation can be enhanced with the 
addition of TGF-β1 at a concentration as low as 0.5 ng/mL.  Although molecular crowding did 
not seem to increase the material yield, it would be interesting to see the outcome if a 10% FBS 
media is used rather than 0.5% FBS media. In addition, other conditions could be considered, 
such as supplementing molecular crowding conditions with TGF-β1 or increasing the length of 
the culture period.  
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